NRX Pharmaceuticals Inc
NRX Pharmaceuticals Inc (NRXP) Covered Calls
As of September 25, 2026, NRXP has 3 covered call opportunities in the coming three months. Return ranges from 64.6 to 142.1% until expiration. Annualized return ranges from 149.4 to 603.1%. The nearest expiration is December 18, 2026. Maximum potential profit is $449.
Read more
Running NRXP covered calls helps you generate consistent income from NRX Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on NRX Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best NRXP covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if NRXP stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling NRXP covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given NRX Pharmaceuticals Inc covered call is worth writing.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Income-focused investors, long-term NRXP holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling NRXP covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best NRX Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile49.21% Neutral
- Market cap (M$)130
- 52 weeks high-40.71%
- 52 weeks low85.19%
- Analyst recommendationStrong Buy
1.00 - Target price$34.67
1055.67% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E—
- Future P/E—
- EPS (ttm)-0.74
- EPS growth next 5 years—
As of September 25, 2026
| 2026-12-18 | 86 | 7.50 | 137.34 | 0.15 | 0.40 | 449.00 | 142.09 | 603.05 | -4.75 | +0.26 | 789 | 0.25 |
| 2026-12-18 | 86 | 5.00 | 58.23 | 0.20 | 0.55 | 204.00 | 64.56 | 273.99 | -6.33 | +0.36 | 2,807 | 0.35 |
| 2027-03-19 | 177 | 5.00 | 58.23 | 0.45 | 0.90 | 229.00 | 72.47 | 149.44 | -14.24 | +0.48 | 345 | 0.45 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best NRXP covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→